Jump to content
 







Main menu
    


Navigation  


●Main page
 ●Contents
 ●Current events
 ●Random article
 ●About Wikipedia
 ●Contact us
 ●Donate
  



Contribute  


●Help
 ●Learn to edit
 ●Community portal
 ●Recent changes
 ●Upload file
  







Search  

































●Create account

●Log in
 









●Create account
 ● Log in
  



Pages for logged out editors learn more  


●Contributions
 ●Talk
  


















Contents

   



(Top)
  


1 Medical uses  




2 References  




3 External links  













Levodopa/benserazide






●العربية
  
Edit links
  








●Article
 ●Talk
  
















●Read
 ●Edit
 ●View history
  







Tools
    


Actions  


●Read
 ●Edit
 ●View history
  



General  


●What links here
 ●Related changes
 ●Upload file
 ●Special pages
 ●Permanent link
 ●Page information
 ●Cite this page
 ●Get shortened URL
 ●Download QR code
 ●Wikidata item
  



Print/export  


●Download as PDF
 ●Printable version
  















Appearance
    

 





From Wikipedia, the free encyclopedia
  

Levodopa/benserazide
Combination of
LevodopaDopamine agonist
BenserazideDecarboxylase inhibitors
Clinical data
Trade namesProlopa, Madopar, others[1]
Pregnancy
category
    • Routes of
    administration    		By mouth
    ATC code
    Legal status
    Legal status
    • AU: S4 (Prescription only)[2]
  • CA: ℞-only[3]
  • UK: POM (Prescription only)[4]
  • In general: ℞ (Prescription only)
    • Identifiers
    KEGG

    Levodopa/benserazide, sold under the brand name Prolopa among others, is a fixed-dose combination medication used for the treatment of Parkinson's disease.[2][3][4]

    Medical uses

    [edit]

    Levodopa/benserazide is indicated for the treatment of Parkinson's disease with the exception of drug-induced parkinsonism.[2][3][4]

    References

    [edit]
    1. ^ "Levodopa".
  • ^ a b c d https://www.guildlink.com.au/gc/ws/ro/pi.cfm?product=ropmadop10710
  • ^ a b c "Prolopa Product information". Health Canada. 25 April 2012. Retrieved 8 January 2023.
  • ^ a b c "Madopar 100 mg/25 mg Dispersible Tablets - Summary of Product Characteristics (SmPC)". (emc). 8 April 2020. Retrieved 9 January 2023.
    • [edit]


    Stub icon

    This pharmacology-related article is a stub. You can help Wikipedia by expanding it.

  • t
  • e

    • Retrieved from "https://en.wikipedia.org/w/index.php?title=Levodopa/benserazide&oldid=1141035854"
    Categories: 
    ●Antiparkinsonian agents
     ●Aromatic L-amino acid decarboxylase inhibitors
     ●Hydrazides
     ●Peripherally selective drugs
     ●Pyrogallols
     ●Pharmacology stubs
     Hidden categories: 
    ●Articles with short description
     ●Short description is different from Wikidata
     ●Use American English from January 2023
     ●All Wikipedia articles written in American English
     ●Use dmy dates from January 2023
     ●Drugs with non-standard legal status
     ●Chemical articles without CAS registry number
     ●Articles without EBI source
     ●Chemical pages without ChemSpiderID
     ●Chemical pages without DrugBank identifier
     ●Articles without InChI source
     ●Articles without UNII source
     ●Articles containing unverified chemical infoboxes
     ●Drugs that are a combination of chemicals
     ●All stub articles
      


    ●This page was last edited on 23 February 2023, at 01:11 (UTC).
    ●Text is available under the Creative Commons Attribution-ShareAlike License 4.0; additional terms may apply. By using this site, you agree to the Terms of Use and Privacy Policy. Wikipedia® is a registered trademark of the Wikimedia Foundation, Inc., a non-profit organization.


    ●Privacy policy
    ●About Wikipedia
    ●Disclaimers
    ●Contact Wikipedia
    ●Code of Conduct
    ●Developers
    ●Statistics
    ●Cookie statement
    ●Mobile view


    Wikimedia Foundation
    Powered by MediaWiki